Hjem › Kardiovaskulær sykdom › California › San Diego
Kliniske studier for Kardiovaskulær sykdom i San Diego, CA
15 studier for Kardiovaskulær sykdom søker deltakere på steder i og rundt San Diego (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RekruttererFase 4
- Kaiser Permanente - San Diego, San Diego
- San Diego Cardiac Center, San Diego
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
RekruttererFase 1
- University of California, San Diego, San Diego
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- Acclaim Clinical Research, San Diego
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RekruttererFase 3
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi unna
Product Surveillance Registry
RekruttererObservasjonsstudie
- San Diego, San Diego
- La Jolla, La Jolla · 11 mi unna
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RekruttererFase 3
- Clinical Trial Site, San Diego
- Clinical Trial Site, La Jolla · 11 mi unna
Zenith® Fenestrated+ Clinical Study
Rekrutterer
- UC San Diego, La Jolla · 11 mi unna
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekrutterer
- Scripps Memorial Hospital, La Jolla · 11 mi unna
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekruttererFase 3
- University of California San Diego, San Diego
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
- VA San Diego Medical Center, San Diego
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruttererFase 3
- Research Site, San Diego
- Research Site, San Diego
- Research Site, La Jolla · 11 mi unna
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekruttererFase 3
- Alliance Clinical Research, San Diego
- University of California San Diego, La Jolla · 11 mi unna
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekrutterer
- Scripps Health, San Diego
Enhancing Capacity in Churches to Implement PA Programs
RekruttererFrivillige helsepersonell ønskes velkommen
- San Diego State University Research Foundation, San Diego
Implementing Food Referrals for Equity and Sustained Health
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Rady Children's Hospital San Diego, San Diego
Kardiovaskulær sykdom-studier i andre byer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC28 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- Nashville, TN18 studier
Andre studier i San Diego
- Ikke-småcellet lungekreft48 studier
- Brystkreft41 studier
- Kreft (alle typer)32 studier
- Prostatakreft31 studier
- Metastatisk kreft30 studier
- Kolorektal kreft25 studier
- Eggstokkreft24 studier
- Pankreaskreft24 studier
- Lungekreft23 studier
- Fedme23 studier
- Hjertesvikt23 studier
- Depresjon21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.